BGB-11417-105 | Maryland Oncology Hematology

BGB-11417-105

Trial Information

A Phase 1b/2 study of BGB-11417 in Monotherapy and in Various Combinations with Dexamethasone and Carfilzomib in Multiple Myeloma

Learn More at ClinicalTrials.gov

Sponsor: BeiGene, Ltd. c/o BeiGene USA, Inc

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Multiple Myeloma

Investigator

Narang

Sponsor

BeiGene, Ltd. c/o BeiGene USA, Inc

« Clinical Trails Main

Quality Care Close to Home

View our locations on map!